• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Study: Glooko’s Diabetes Mobile App Improved Glucose & A1C Rates

by HITC Staff 06/09/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Study Glooko’s Diabetes App Improved Glucose & A1C Rates

Diabetes data management company Glooko announced that its mobile app was associated with a drop in average blood glucose, estimated A1C (eA1C) and hyperglycemia rates in people with diabetes, according to results of two retrospective studies. Furthermore, usage of the Glooko mobile app was also associated with an increase in blood glucose test rate. Increased blood glucose testing rates have been shown to directly correlate with improvements in glycemic control, as evidenced by this retrospective study and other studies as well.

Glooko is a mobile health app and cloud-based diabetes management system that enables PWDs to upload their self-monitored blood glucose SMBG, insulin pump, diet, exercise and medication data to the cloud and share those data with their care team. In addition, the system allows users to visualize their glycemic patterns by time period on their smartphone, and both digitally log and review that information alongside their diet, exercise and medication usage.

Study Overview

The retrospective studies show that Glooko mobile app users who used the app for self-management experienced the following clinical results compared to a control group of users who did not use the Glooko mobile app, but did upload their data in the clinic:

• Average Blood Glucose: After two months, mobile users experienced an additional 3.54% drop in average BG, over control group users.

• Estimated A1C (eA1C): The studies showed a drop in eA1C among Glooko mobile app users between 0.3% and 0.5% down to 7.14% – 6.98% after two months of using the Glooko mobile app alone.

• Reduction in hyperglycemic rates: Glooko mobile users exhibited an additional decrease in the probability of experiencing hyperglycemic events by 4.38% per month, compared to the control group (p<0.01). Overall, a mobile user could expect a 10.65% decrease in the probability of hyperglycemic events by the end of two months.

• Blood Glucose Test Rate: In addition, there was a statistically significant increase in the average blood glucose test rate of between 16.33% – 34.15% (p<0.01) increase after two months, compared to control.

• Relationship Between Test Rate and Average BG: These increases in blood glucose test rate show a modest but significant correlation to the percent decrease in BG Average (ρ=0.22, p<0.01) indicating that people with diabetes who increased their test rates more, compared to the previous month, also exhibited a decrease in average BG.

“We are thrilled to see this additional clinical evidence that shows the positive impact Glooko can have on people with diabetes,” Rick Altinger, CEO of Glooko said in a statement. “Glooko’s mission has always been to improve the clinical outcomes for people with diabetes by making diabetes management easier through digital tools. Our user satisfaction rates coupled with this clinical evidence adds credence to the investments that digital health companies have been making to improve the lives of people with chronic diseases.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: diabetes app, Diabetes Management, Diabetes Management Platform, Diabetes Prevention Platform, digital diabetes management platform, Glooko

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |